Healthcare · Hepatitis C prevalence

Hepatitis C prevalence in USA in 2026

In 2026, the proportion of hepatitis C carriers in the United States reached 0.9 %, placing the country 85-th globally. The epidemic has two waves: the first occurred in the 1960s–1980s through blood transfusions before screening was introduced; the second, ongoing wave is linked to the opioid crisis and intravenous drug use in rural Appalachia and New England. The advent of highly effective direct-acting antivirals since 2013 has dramatically changed the outlook, but treatment coverage remains uneven.

Data for 2026 · unit: %
Position

USA world ranking

#85 / 197

Country position on the scale from last to first place for this indicator.

US
#85
#197#1
Trend

Change over time

Change in indicator over the available period.

1.5
1990
1.8
2000
1.3
2010
1.0
2020
0.9
2026

Values — %

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Hepatitis C prevalence in USA — how much?
Based on 2026 data — 0.9 %. This is rank #85 out of 197 countries.
What is USA's rank by Hepatitis C prevalence?
USA ranks #85 out of 197 countries in the world ranking by «Hepatitis C prevalence».
How has Hepatitis C prevalence changed in USA?
Over the available period the indicator changed from 1.5 to 0.9 %.